Covered recipient · General Payments record
GUOFANG WANG
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2024
$2,886.98
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $427.21 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $284.72 | 10 |
| ABBVIE INC. | $61.70 | 2 |
| PFIZER INC. | $31.08 | 2 |
| Meridian Bioscience Inc. | $26.92 | 1 |
| Hologic Sales and Service, LLC | $22.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.82 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106305209 | CMS |
| ABBVIE INC. | $28.88 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106305211 | CMS |
| Gilead Sciences, Inc. | $0.52 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838186 | CMS |
| Gilead Sciences, Inc. | $12.83 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838188 | CMS |
| Gilead Sciences, Inc. | $14.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838190 | CMS |
| Gilead Sciences, Inc. | $20.37 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838192 | CMS |
| Gilead Sciences, Inc. | $121.32 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838194 | CMS |
| Gilead Sciences, Inc. | $16.53 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838196 | CMS |
| Gilead Sciences, Inc. | $25.93 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838198 | CMS |
| Gilead Sciences, Inc. | $23.96 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838200 | CMS |
| Gilead Sciences, Inc. | $31.73 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838202 | CMS |
| Gilead Sciences, Inc. | $16.94 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133838204 | CMS |
| Hologic Sales and Service, LLC | $22.79 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084878991 | CMS |
| Meridian Bioscience Inc. | $26.92 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137917266 | CMS |
| PFIZER INC. | $16.26 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132019004 | CMS |
| PFIZER INC. | $14.82 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131279564 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.